1. Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, et al. A white paper: the product of a pancreas cancer think tank. Cancer Res. 2001; 61:4923–4932. PMID:
11406572.
2. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, et al. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer. 2007; 110:738–744. PMID:
17580363.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58:71–96. PMID:
18287387.
Article
4. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994; 81:102–107. PMID:
7906180.
Article
5. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000; 4:567–579. PMID:
11307091.
Article
6. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003; 27:324–329. PMID:
12607060.
Article
7. Dalton RR, Sarr MG, van Heerden JA, Colby TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992; 111:489–494. PMID:
1317976.
8. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996; 223:506–511. discussion 511-512. PMID:
8651741.
Article
9. Magistrelli P, Antinori A, Crucitti A, La Greca A, Masetti R, Coppola R, et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol. 2000; 74:36–40. PMID:
10861607.
Article
10. Hsu CC, Wolfgang CL, Laheru DA, Pawlik TM, Swartz MJ, Winter JM, et al. Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg. 2012; 16:753–761. PMID:
22311282.
Article
11. Barugola G, Partelli S, Marcucci S, Sartori N, Capelli P, Bassi C, et al. Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol. 2009; 16:3316–3322. PMID:
19707831.
Article
12. Takamori H, Hiraoka T, Kanemitsu K, Tsuji T, Hamada C, Baba H. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer: under-analysis of cumulative survival curve. World J Surg. 2006; 30:213–218. PMID:
16425074.
13. Kennedy EP, Yeo CJ. The case for routine use of adjuvant therapy in pancreatic cancer. J Surg Oncol. 2007; 95:597–603. PMID:
17230543.
Article
14. Polterauer S, Grimm C, Seebacher V, Rahhal J, Tempfer C, Reinthaller A, et al. The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer. Int J Gynecol Cancer. 2010; 20:1052–1057. PMID:
20683416.
Article
15. Shimoda M, Katoh M, Kita J, Sawada T, Kubota K. The Glasgow prognostic score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy. 2010; 56:501–506. PMID:
21099223.
Article
16. Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. 2014; 44:676–682. PMID:
24750233.
Article
17. Shibata K, Matsumoto T, Yada K, Sasaki A, Ohta M, Kitano S. Factors predicting recurrence after resection of pancreatic ductal carcinoma. Pancreas. 2005; 31:69–73. PMID:
15968250.
Article
18. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009; 16:1727–1733. PMID:
19396496.
Article
19. Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997; 15:928–937. PMID:
9060530.
Article
20. Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, et al. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin N Am. 1998; 7:183–197. PMID:
9443995.
Article